1. Home
  2. MUC vs BHVN Comparison

MUC vs BHVN Comparison

Compare MUC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings California Quality Fund Inc.

MUC

Blackrock MuniHoldings California Quality Fund Inc.

HOLD

Current Price

$10.84

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$12.81

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUC
BHVN
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
MUC
BHVN
Price
$10.84
$12.81
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
$30.36
AVG Volume (30 Days)
292.8K
3.6M
Earning Date
01-01-0001
03-02-2026
Dividend Yield
4.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.19
$7.48
52 Week High
$11.30
$44.28

Technical Indicators

Market Signals
Indicator
MUC
BHVN
Relative Strength Index (RSI) 56.36 57.87
Support Level $10.72 $10.35
Resistance Level $10.94 $14.01
Average True Range (ATR) 0.09 1.25
MACD 0.01 0.21
Stochastic Oscillator 65.52 75.10

Price Performance

Historical Comparison
MUC
BHVN

About MUC Blackrock MuniHoldings California Quality Fund Inc.

BlackRock MuniHoldings California Quality Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes and California personal income taxes. The fund mainly invests in municipal obligations exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and California personal income taxes. Under normal market conditions, it invests a majority of its managed assets in investment-grade municipal obligations with remaining maturities of one year or more at the time of investment. It can also invest in below investment-grade securities, or directly in such securities or synthetically through the use of derivatives.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: